SCHEMBL4903138

SCHEMBL4903138

Cc1ccc(S(=O)(=O)NCCc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C19 P33261 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
LMNA P02545 3/20 0.53
MAPT P10636 2/20 0.53
RECQL P46063 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
FFAR1 O14842 1/20 0.52
FFAR4 Q5NUL3 1/20 0.52
TP53 P04637 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
ALDH1A1 P00352 2/20 0.51
PRMT1 Q99873 1/20 0.50
GAA P10253 1/20 0.50
METAP2 P50579 1/20 0.50
SGMS1 Q86VZ5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905405 0.91 POLB (0.58) POLBCYP1A2CYP2D6CYP2C19TDP1
SCHEMBL4905692 0.89 LMNA (0.56) POLBCYP1A2CYP2D6CYP2C19TDP1
SCHEMBL4904049 0.89 POLB (0.53) POLBCYP1A2CYP2D6CYP2C19TDP1
SCHEMBL4904194 0.88 POLB (0.54) POLBCYP1A2CYP2C19TDP1LMNA
SCHEMBL4899418 0.86 ALDH1A1 (0.58) POLBCYP1A2CYP2D6CYP2C19TDP1
SCHEMBL4897468 0.84 ALDH1A1 (0.55) POLBCYP1A2CYP2D6CYP2C19TDP1
SCHEMBL5386741 0.81 POLB (0.56) POLBLMNAMAPTFFAR1FFAR4
SCHEMBL27720168 0.81 LMNA (0.59) POLBTDP1LMNAMAPTRECQL
SCHEMBL4904177 0.81 MMP2 (0.53) POLBCYP1A2CYP2D6CYP2C19TDP1
SCHEMBL4905940 0.80 LMNA (0.53) POLBCYP1A2CYP2D6CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885CYP1A2 2009/4885CYP2D6 2484/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD POLB 1807/4885CYP1A2 2009/4885CYP2D6 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.